Nanobiotix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,395	943	143	313	126	254
Market Cap Growth	897.35%	558.09%	-54.17%	147.96%	-50.42%	-46.44%
Enterprise Value	1,437	966	126	345	108	203
Last Close Price	28.76	19.50	3.02	6.64	3.62	7.31
PS Ratio	42.79	28.95	-19.93	8.64	26.42	96.13
PB Ratio	-16.51	-11.17	-2.18	-169.73	-4.66	9.50
P/TBV Ratio	-	-	-	-	-	9.50
EV/Sales Ratio	44.10	29.63	-	9.53	22.66	76.63
Debt / Equity Ratio	-1.13	-1.13	-0.77	-27.44	-1.97	1.72
Net Debt / Equity Ratio	-0.50	-0.50	-0.02	13.41	-0.44	-1.41
Net Debt / EBITDA Ratio	-4.06	-4.06	-0.02	1.09	-0.27	0.83
Net Debt / FCF Ratio	-1.25	-1.25	-0.06	1.93	-0.32	1.26
Asset Turnover	0.48	0.48	-	0.47	0.06	0.02
Quick Ratio	1.05	1.05	0.99	1.68	1.23	2.38
Current Ratio	1.09	1.09	1.04	1.75	1.38	2.53
Return on Equity (ROE)	-	-	-	-	-	-96.66%
Return on Assets (ROA)	-10.06%	-10.06%	-52.89%	-19.72%	-35.38%	-25.00%
Return on Capital Employed (ROCE)	-106.10%	-106.10%	-804.70%	-55.10%	-209.40%	-72.60%
Earnings Yield	-1.72%	-2.54%	-47.53%	-12.69%	-45.21%	-18.47%
FCF Yield	-2.43%	-3.60%	-14.23%	-4.09%	-29.48%	-11.83%
Buyback Yield / Dilution	-1.17%	-1.17%	-27.99%	-5.96%	-0.34%	-42.43%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.